$AZN AstraZeneca said this week it had the capacity to manufacture one billion doses of the University of Oxford’s potential Covid-19 vaccine and could begin supply in September. The pharmaceutical firm said it has secured the first agreements for at least 400 million doses of the vaccine. In Scotland, the University of Glasgow will support the trials in collaborations with NHS Greater Glasgow and Clyde. Dr Jennifer Armstrong, medical director of NHS Greater Glasgow and Clyde, said: “We’re proud to have NHS Greater Glasgow and Clyde join the global effort in finding an effective vaccine for Covid-19. “Our dedicated team of health and care staff have put patients first every step of the way as we responded to this virus.”
  • 1
1 Like